EBITDA increases by 22.7 per cent Y-o-Y to Rs 604 million from Rs 492 million
Dr Lal PathLabs has announced the financial results for the quarter ended June 30, 2016. The operating revenue increased by 17.7 per cent Y-o-Y to Rs 2228 million vs Rs 1893 million in the previous year. Underlying volume growth is 15 per cent. EBITDA increased by 22.7 per cent Y-o-Y to Rs 604 million from Rs 492 million in the same quarter last year. Normalised EBITDA increased by 17.3 per cent after adjusting for ESOP provisions in PY financials.
EBITDA Margin was 27.1 per cent for Q1 2016 vs 26 per cent in Q1 2015. Profit after Tax increased by 29.7 per cent to Rs 402 million from Rs 310 million; margins of 18 per cent vs 16.4 per cent last year in Q1
EH News Bureau